San Francisco County OBOT Pilot: Pharmacy Aspects

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Care Coordinator Roles and Responsibilities
Bakheet Aldosari, Ph.D. Health 305 Health Information Management Bakheet Aldosari, Ph.D.
“Medication Units” (Opioid Treatment Programs) Drug Enforcement Administration James “Jim” Arnold Chief, Policy Unit Office of Diversion Control D E A.
Drug Utilization Review (DUR)
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
a judgment of what constitutes good or bad Audit a systematic and critical examination to examine or verify.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
An NTP Affiliated Office-Based Opiate Treatment (OBOT) Program in a Public Health Setting Alice Gleghorn, PhD SFDPH OBOT Director.
Solution Overview for NIPDEC- CDAP July 15, 2005.
Aurora Employee Assistance Program
Primary Care Workforce Summit November 29, 2012 Country Springs Hotel, Waukesha Primary Care Workforce Summit Pharmacy Perspective Kate Hartkopf, PharmD.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Interprofessional Education M. David Stockton, MD, MPH Professor Department of Family Medicine UT Graduate School of Medicine Sept. 4, 2013.
Clinical Pharmacy Part 2
Florida Agency for Health Care Administration Florida Center for Health Information and Policy Analysis Florida Public Health Association - Medical Director’s.
For Pain or Not for Pain: Methadone Madness
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
Promoting the Use of Injectable Naltrexone (Vivitrol) in Colorado Staff Training, Patient Screening, Medication Administration, and Payor Source Development.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Documentation of Care Provided Patient’s care - who should do it? WHY DOCUMENT? When should it occur? Where should it be documented? How should it be documented?
Baltimore Buprenorphine Initiative Advancing Recovery Project Baltimore City, Maryland January 14, 2010.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
San Francisco County OBOT Pilot: Pharmacy Aspects Sharon Kotabe, PharmD Associate Administrator for Pharmaceutical Services Associate Clinical Professor.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Expanding Authority for MAT, New Initiatives and Next Steps Brad DeCamp SOTA Ohio Mental Health & Addiction Services.
 the study of the rightness or wrongness of human conduct.  In any situation involving two or more individuals, values may come into conflict and ethical.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Who are Health-System Pharmacists? Pharmacists are healthcare professionals with extensive education and training in the pharmaceutical sciences. Education.
Bringing Hepatitis C Treatment into the Medical Home A Pilot Program for Drug Users Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission.
Introduction to Careers in Acute and Ambulatory Settings.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Developing role of community pharmacy in responding to the needs of people with drug problems Karen Melville Principal Pharmacist TSMS NHS Tayside.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
Domain of Nursing The specific domain of nursing is – People’s unique responses to and experience of health, illness, frailty, disability and health-related.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
Refuah Community Health Collaborative (RCHC) PPS
Medication Assisted Treatment
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
PHARMACIST : A HEALTH CARE PROFESSIONAL
The Many Careers of Pharmacy
Alice Gleghorn, PhD SFDPH OBOT Director
Introduction to Clinical Pharmacy
Health Information Security and Privacy Collaborative (HISPC) Overview
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Batch Prescribing Repeat Dispensing
CHAPTER 4 Information Management in Pharmacy.
Pharmacist- Career Opportunities
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Health Care Providers and Professionals
Survey Readiness RIDEOUT HEALTH Kimberly Black
Primary Care Integration
CLINICAL INFORMATION SYSTEM
The Power of Protocols for Sustaining SBIRT
Optum’s Role in Mycare Ohio
Pharmacy practice and the healthcare system Ola Ali Nassr
11 iii. Define management and supervision roles and responsibilities
Ch 18: Pharmacy.
Compounded Drugs and Lack of Premarket FDA-Approval
Hospital pharmacy.
A Training For Multidisciplinary Addiction Professionals
Medically assisted treatment
SAMPLE ONLY Dominion Health Center: Your Community Partner for Excellent Care (or another defining message) Dominion Health Center is a community health.
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
Medication Assisted Treatment of Opioid Use Disorder
Presentation transcript:

San Francisco County OBOT Pilot: Pharmacy Aspects Sharon Kotabe, PharmD Associate Administrator for Pharmaceutical Services Associate Clinical Professor of Pharmacy, UCSF

In the beginning…… Pharmacy Subcommittee formed, November 1999 Members represented County Health Department Local School of Pharmacy State Board of Pharmacy State Poison Control System Local chain, independent & hospital pharmacies Narcotic Treatment Programs (NTPs) and free clinics

Pharmacy Subcommittee Charge “ To develop and recommend a ‘best practices’ model to create medically appropriate and geographically-convenient dispensing of methadone in a PHARMACY-BASED SETTING in San Francisco”

Pharmacy Subcommittee Activities Identified barriers to pharmacist participation in project Pharmacists not included in “traditional” maintenance program models and in California, restricted by law from dispensing maintenance opiates to known addicts Negative perceptions & beliefs re: addiction Reimbursement for time necessary to provide appropriate services

Pharmacy Subcommittee Activities Identified benefits of pharmacist participation in program Expertise counseling patients on medication and drug therapy Availability of patient’s entire drug profile for drug-drug interaction and contraindication monitoring Increased access to treatment through local “neighborhood” pharmacies

Pharmacy Subcommittee Activities Reviewed State and Federal regulations for “traditional” narcotic treatment programs Reviewed materials training materials used to educate pharmacy students about addiction and addiction pharmacology from various schools of pharmacy

Pharmacy Subcommittee Activities Met with pharmacists engaged in office-based treatment models in other States Matched zip-codes of clients already in treatment with pharmacy locations to target potential dispensing pharmacies Conducted focus groups with pharmacists from 10 zip-codes with highest number of current clients

Focus Group Comments Support for expanding access to treatment Participation perceived as a natural expansion of professional role and responsibilities and welcomed challenge of learning new skills Suggestions that program start slowly with fewer initial clients, and for scheduled “appointment times”

Pharmacy Subcommittee Recommendations (February 2001) Training Integrate with training for physicians, counselors and others to foster collaborative, team-approach to care Focus on: (1) “mechanics” of maintenance treatment and, (2) “raising consciousness” on nature of addiction

Recommendations (continued)… Create central database for ready access to relevant client information and recording dose administration Allow pharmacies to establish dosing “appointments” as dictated by workload Require establishment of dosing areas separate and private from main pharmacy counseling windows

Recommendations (continued)… Provide adequate security Provide access to “on-call” system to advise pharmacists dealing with complex client issues Pharmacists provide medication counseling, counselors and physicians provide drug abuse counseling Provide adequate remuneration

….. and at last! First patient enrolled, July 2003 Community pharmacy participation Corporate vs. individual pharmacist views Corporate view prevails County operated pharmacies Hospital-based outpatient pharmacy (methadone dispensing) Mental health clinic pharmacy (buprenorphine dispensing)

Basic Program Components All pharmacists involved in the program undergo extensive training provided by the California Society of Addiction Medicine Central database with pertinent client demographic and clinical information Pharmacists record observed and take home dosing in database Communication and clinical data sharing through “SOAP” notes format

Basic Program Components Program licensure allows exemption from Board of Pharmacy prescription requirements “On-call” OBOT program staff to assist with problems Physical modifications were made to enhance security and dosing area privacy Program uses methadone tablets (vs. liquid or diskette), or SuboxoneR

Observations, 1 year later Establishing dosing “appointments” works! Estimate of pharmacist time needed for each observed dosing/take home dispensing (5 minutes) too low Regulatory agencies - e.g. DEA, state NTP licensing agency - complimentary of pharmacist record keeping, security, and professional services provided to clients

more observations…... Rapport between pharmacist and client quickly and easily established Pharmacists enjoy client interaction and expanded responsibilities Pharmacists initially reluctant to “volunteer”, later filed labor grievance to be allowed to participate Clients prefer dosing and receiving take home doses in a pharmacy setting

Lessons Learned Listen to the “experts” - especially those who actually do the work Local buy-in may not be enough, engage corporate decision makers if possible Initial concerns about major legal and regulatory obstacles did not materialize Flexibility, open-mindedness, and patience are required traits for anyone involved in a pilot program

Questions? Sharon Kotabe, PharmD (415) 206-2325 sharon_kotabe@sfdph.org